Search: onr:"swepub:oai:DiVA.org:oru-86799" > Relapse risk after ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05039naa a2200577 4500 | |
001 | oai:DiVA.org:oru-86799 | |
003 | SwePub | |
008 | 201026s2021 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:uu-428961 | |
009 | oai:DiVA.org:liu-171405 | |
009 | oai:prod.swepub.kib.ki.se:145036834 | |
009 | oai:gup.ub.gu.se/297595 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-867992 URI |
024 | 7 | a https://doi.org/10.1080/08039488.2020.18346172 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4289612 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1714052 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1450368342 URI |
024 | 7 | a https://gup.ub.gu.se/publication/2975952 URI |
040 | a (SwePub)orud (SwePub)uud (SwePub)liud (SwePub)kid (SwePub)gu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Kalling, Styrbjörnu Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD),Uppsala Univ, Sweden4 aut |
245 | 1 0 | a Relapse risk after in-ward electroconvulsive therapy for acute polymorphic psychotic disorder |
264 | c 2020-10-23 | |
264 | 1 | b Taylor & Francis,c 2021 |
338 | a print2 rdacarrier | |
500 | a Funding Agency:Centre for Clinical Research Sormland 75602 | |
500 | a Funding Agencies|Centre for Clinical Research Sormland [75602] | |
520 | a PURPOSE: Acute polymorphic psychotic disorder (APPD) without symptoms of schizophrenia is a serious psychiatric condition. APPD can be effectively treated with electroconvulsive therapy (ECT), but little is known about relapse prevention after ECT for APPD.MATERIALS AND METHODS: This was a retrospective register-based study conducted with 97 patients with APPD (ICD-10 diagnosis F23.0). We estimated the rates of readmission and suicide, and the prognostic factors of these outcomes after ECT. We combined data from several national Swedish registers and used Cox's regression analysis to identify demographic factors, disease characteristics, and relapse preventive treatments that predicted time to readmission or suicide (relapse). Data registered between 2011 and 2016 were used in the study.RESULTS: Twenty percent of cases relapsed within a year. Thereafter, relapse rate was low. Two cases died during follow-up, whereof one by suicide. Anxiolytic treatment, lamotrigine treatment, and having more than four previous psychiatric hospital admissions were associated with shorter time to relapse. The most robust of these associations was between anxiolytics and relapse risk.CONCLUSIONS: The first year after discharge from APPD is the period associated with the highest risk of relapse. Having many previous admissions was associated to relapse risk after ECT for APPD. The associations between anxiolytics, lamotrigine, and relapse are uncertain and might be influenced by indication bias. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Psykiatri0 (SwePub)302152 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Psychiatry0 (SwePub)302152 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
653 | a Acute polymorphic psychotic disorder | |
653 | a electroconvulsive therapy | |
653 | a relapse prevention | |
700 | 1 | a Brus, Ole,d 1982-u Örebro universitet,Institutionen för medicinska vetenskaper,Clinical Epidemiology and Biostatistics,Orebro Univ, Sweden4 aut0 (Swepub:oru)oebs |
700 | 1 | a Landén, Mikael,d 1966u Gothenburg University,Göteborgs universitet,Karolinska Institutet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xlandt |
700 | 1 | a Lundberg, Johanu Karolinska Institutet4 aut |
700 | 1 | a Nordanskog, Pia,d 1971-u Linköpings universitet,Centrum för social och affektiv neurovetenskap,Medicinska fakulteten,Region Östergötland, Psykiatriska kliniken i Linköping4 aut0 (Swepub:liu)piano33 |
700 | 1 | a Nordenskjöld, Axel,d 1977-u Örebro universitet,Institutionen för medicinska vetenskaper,University Health Care Research Centre,Orebro Univ, Sweden4 aut0 (Swepub:oru)alnd |
710 | 2 | a Uppsala universitetb Centrum för klinisk forskning i Sörmland (CKFD)4 org |
773 | 0 | t Nordic Journal of Psychiatryd : Taylor & Francisg 75:3, s. 201-206q 75:3<201-206x 0803-9488x 1502-4725 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-86799 |
856 | 4 8 | u https://doi.org/10.1080/08039488.2020.1834617 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-428961 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-171405 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:145036834 |
856 | 4 8 | u https://gup.ub.gu.se/publication/297595 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.